---
up: 
down: 
related: 
tags: []
type:
  - "[[SUB.LO.C.PEX.ANZCA]]"
dg-publish: true
title: 2.3_VariabilityInDrugResponse
date created: Wednesday, March 5th 2025, 20:25:14
date modified: Tuesday, March 25th 2025, 16:09:22
---

## 2.3 Variability in Drug Response

This section covers the factors that contribute to variations in drug responses between individuals and in different clinical scenarios, including pharmacogenetics, drug interactions, and physiological and pathological alterations.

### Learning Objectives

- [[ANZCA.2.3.1_BT_GS.1.14_Individual_Drug_Response_Variations]]
- [[ANZCA.2.3.2_BT_GS.1.15_Tachyphylaxis_Tolerance_Mechanisms]]
- [[ANZCA.2.3.3_BT_GS.1.16_Pharmacokinetic_Pharmacodynamic_Alterations_Elderly_Obesity]]
- [[ANZCA.2.3.4_BT_GS.1.17_Pharmacokinetic_Pharmacodynamic_Alterations_Pathological_Disturbance]]
- [[ANZCA.2.3.5_BT_GS.1.19_Drug_Interaction_Mechanisms]]
- [[ANZCA.2.3.6_BT_GS.1.20_Pharmacogenetic_Variation_Clinical_Importance]]
- [[ANZCA.2.3.7_BT_GS.1.21_Isomerism_Clinical_Importance]]
